Dyne Therapeutics, Inc. DYN Restricted Cash And Other Assets Noncurrent

Restricted Cash And Other Assets Noncurrent at other companies

Kaltura, Inc.KLTR

$1.25M+13.2%

The Pennant Group, Inc.PNTG

$27.29M+14.7%

Recursion Pharmaceuticals, Inc.RXRX

$5.75M+2.2%

CVS HealthCVS

$208M+6.7%

Eos Energy Enterprises, Inc.EOSE

$15M-51.8%

Clear SecureYOU

$2.85M+2.8%

FAQ

What is Dyne Therapeutics, Inc.'s restricted cash and other assets noncurrent?

Dyne Therapeutics, Inc. (DYN) reported restricted cash and other assets noncurrent of $15.59M in Q1 2026.

How has Dyne Therapeutics, Inc.'s restricted cash and other assets noncurrent changed year-over-year?

Dyne Therapeutics, Inc.'s restricted cash and other assets noncurrent increased by 702.7% year-over-year, from $1.94M to $15.59M.

What is the long-term trend for Dyne Therapeutics, Inc.'s restricted cash and other assets noncurrent?

Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s restricted cash and other assets noncurrent has grown at a 46.6% compound annual growth rate (CAGR), from $2.3M to $15.6M.

What does restricted cash and other assets noncurrent mean?

This metric represents cash, cash equivalents, or other financial assets that are legally restricted from withdrawal or usage for general corporate purposes for a period exceeding one year. These assets are typically held as collateral for long-term obligations, such as facility leases, debt covenants, or specific contractual commitments. Monitoring this balance provides insight into the portion of the company's liquidity that is effectively locked and unavailable to fund ongoing research, development, or operational activities.